U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07940881) titled 'A Multicenter, Open-label, Phase 1/1b, Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SI-B037 in Solid Tumors' on Nov. 10.
Brief Summary: The objective of the study is to evaluate the safety and tolerability of SI-B037 in participants with locally advanced or metastatic solid tumors.
Study Start Date: Aug. 24
Study Type: INTERVENTIONAL
Condition:
Locally Advanced /Metastatic Solid Tumors
Locally Advanced / Metastatic Solid Tumors
First in Human
Metastatic Solid Cancers
Non Small Cell Lung Cancer
NSCLC
Lung Cancer (Diagnosis)
Lung Cancer (NSCLC)
Lung Cancer (Non-Small Cell)
Lung Cancer (Locally Advan...